Author Archives: Gastroenterology Journal
Eliminating pathobionts with bacteriophages: a novel approach to reduce gut inflammation in IBD?
Final analysis of diagnostic endoscopic resection followed by selective chemoradiotherapy for stage I esophageal cancer: JCOG0508
Diversity, Equity, and Inclusion in Gastroenterology and Hepatology: A Survey of Where We Stand
In the setting of increasing attention to representation in medicine, we aimed to assess current perspectives of racial and ethnic workforce diversity and health care disparities among gastroenterology (GI) and hepatology professionals in the United St… Continue reading
Bacteroides vulgatus SNUG 40005 restores Akkermansia depletion by metabolite modulation
Weight loss and exercise intervention have been reported to increase the interaction between Bacteroides spp. and Akkermansia muciniphila (Am), although the underlying mechanisms and consequences of the interaction remain unknown. Continue reading
A deCIDEdly new germline mutation that protects against liver disease
Current Best Practice in Hepatitis B Management & Understanding Long-Term Prospects for Cure
The hepatitis B virus (HBV) is a major cause of cirrhosis and hepatocellular carcinoma worldwide. Despite an effective vaccine the prevalence of chronic infection remains high. Current therapy is effective at achieving on-treatment but not off-treatmen… Continue reading
DISPARITIES IN ACCESS TO ENDOSCOPY FOR PATIENTS WITH UPPER GASTROINTESTINAL BLEEDING PRESENTING TO EMERGENCY DEPARTMENTS
VONOPRAZAN VERSUS LANSOPRAZOLE FOR HEALING AND MAINTENANCE OF HEALING OF EROSIVE ESOPHAGITIS: A RANDOMIZED TRIAL
For decades, proton pump inhibitors (PPIs) have been the mainstay of treatment for erosive esophagitis. The potassium-competitive acid blocker vonoprazan provides more potent acid inhibition than PPIs but data on its efficacy for erosive esophagitis ar… Continue reading